CAR T-cell therapyB7-H3-directed CAR T-cell therapyResiquimodPOx-RmedulloblastomaG3MB
…G3MB) is the most aggressive medulloblastoma subgroup. Although CAR T-cell therapy is promising, it has shown limited efficacy in G3MB due to poor…
7,227articles mentioning treatments
16,644treatment mentions
4,719distinct treatments extracted
0%of mentions human-reviewed
All extracted treatments
Showing 1,141–1,200 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.
food supplements1multi-ion therapy1A-CRA1Antithrombotic therapies1CA1CAB/RPV LA1CACB1CWCPC1DT1Delayed treatment intensification1EUS-CG1EVT-capable1FFX1FURS1GTx1Haematoma block1IO1IPFT1IV/IM SACT1Immediate septoplasty1Incretin-based therapies1LA-CAB/RPV1Limb salvage1NACI1NDIs1Oscillometry1PRT1PVEfLR1Parenteral chemotherapy1Primary repair1ShangRing EIMC1TESS1Verbal counselling1Z-POEM1diaphragmatic stimulation1epidural neuroplasty1frenotomy1haematopoietic stem cell transplant1heDMTs1internal fixation1laughter yoga1leDMTs1psychotropic drug prescription1shoulder replacement surgery1telestroke1CES1CESDT1CMH1Capsule sponge testing1Compression therapy1DCB1DMEK1ECPR1EVOKE therapy1FLST1Focal therapy1GLP-1-based therapy1GPD-CBT1ICAS1IERITA1
Articles mentioning treatments
7,227 articles · page 130 of 603RPT177Lu-PSMA-617metastatic castration-resistant prostate cancermetastatic castration-resistant prostate cancer (mCRPC)mCRPCcyclophosphamideCyNCT03873805
…stry were monitored to evaluate the efficacy and safety.Results RPT and Cy treatment alter the endogenous immune landscape in the m…
IL-12 GEMy therapyCy/FluOsteosarcomacyclophosphamiderhabdomyosarcomafludarabineNational Institutes of Health
…stasis, making it an important disease for continued studies of IL-12 GEMy therapy.Methods F42010 murine syngeneic osteosarcoma cells were orthoto…
stem cell treatmentsadoptive cell therapiesadoptive cell therapycancerantibody therapies
… drugs such as antibody therapies, adoptive cell therapies, and stem cell treatments. Understanding complex biological systems requires extensive te…
tdRT_SLNAdoptive cell therapyUniversity of California San DiegoHead and neck squamous cell carcinoma (HNSCC)Gleiberman Head and Neck Cancer CentertdRTHNSCC
…RT_SLN mice remained tumor-free for the entirety of experiment. tdRT_SLN also showed highest survival ( figure 1B-C). Data was analyzed …
E7 TCR-T cell therapyT cell receptor (TCR)-T cell therapymelanomasynovial cell sarcomasynovial sarcomahuman papillomavirus (HPV)-associated cancersNIH IRB
…vardict and strelka.Results Patient 4 had primary resistance to E7 TCR-T cell therapy due to a nonsense mutation at amino acid position 51 in the α1 …
neoadjuvant immunochemotherapyNSCLC
…e II, IIIA, and IIIB (N2) NSCLC (AJCC 8th edition) treated with neoadjuvant immunochemotherapy, with or without adjuvant therapy. Baseline characteristics, tr…
chemotherapystereotactic body radiotherapyNivolumabBiliary tract canceripilimumabPembrolizumabgemcitabineGranzyme Bcisplatin
… with chemotherapy as first-line therapy for BTC is superior to chemotherapy alone, most patients still do not benefit from treatment.2 This…
platinum chemotherapyplatinum-doublet chemotherapyanti-PD-(L)1 therapymNSCLCdocetaxelpembrolizumabvibo/pembrovibostolimab
…axel in mNSCLC previously treated with anti-PD-(L)1 therapy and platinum chemotherapy. No significant difference in PFS was observed between vibo/pem…
lymphodepleting chemotherapyLDCLEU011solid tumorssolid tumoursLEU01101ClinicalTrials.govNorth East - York Research Ethics Committee
… linear CAR. The trial hypothesis is that LEU011, combined with lymphodepleting chemotherapy (LDC), will be safe and tolerable, and will elicit efficacy in …
RPT[67Cu]Cu-LLP2Aneuroblastomasolid tumors[ 67Cu]Cu-LLP2A67Cu]Cu-LLP2Ahematological malignanciesSK-N-ASNIH institutional IACUCNB
…he tumors in both SK-N-AS and IMR-5.Conclusions [ 67Cu]Cu-LLP2A RPT improves CAR T-cell efficacy by direct tumoricidal effects and …